Michael J. Kelly, MD, MPH, MS^1*, Susan K Parsons, MD, MRP^2*, David C. Hodgson, MD^3*, Joshua T Cohen, PhD^4*, Jennifer M Yeh, MD, PhD^5*, Jeremy S. Abramson, MD⁶, Debra L. Friedman, MD, MS⁷, Tara O Henderson, MD, MPH⁸, Peter W Johnson, MD⁹, Stephen G Pauker, MD^10*, John M. Raemaekers, MD, PhD¹¹, Jane N. Winter, MD¹², Kara M. Kelly, MD¹³, Ralph M. Meyer, MD¹⁴, Sharon M Castellino, MD¹⁵ and Andrew M. Evens, DO, MSc¹⁶

¹Divison of Pediatric Hematology / Oncology, Department of Pediatrics, The Floating Hospital for Children at Tufts Medical Center, Boston, MA
²Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Departments of Medicine and Pediatrics, Boston, MA
³Radiation Medicine Programme, University of Toronto,Princess Margaret Cancer Centre, Toronto, ON, Canada
⁴Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA
⁵Center for Health Decision Science, Harvard School of Public Health, Boston, MA
⁶Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
⁷Vanderbilt-Ingram Cancer Center, Nashville, TN
⁸Comer Children's Hospital, University of Chicago, Chicago, IL
⁹Cancer Research UK Clinical Centre, University of Southampton, Southampton, United Kingdom
¹⁰Division of Clinical Decision Making / Departments of Medicine and Psychiatry, Tufts Medical Center, Boston, MA
¹¹Department of Hematology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
¹²Department of Medicine-Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL
¹³Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Medical Center, New York, NY
¹⁴Departments of Oncology, Medicine and Community Health and Epidemiology, NCIC Clinical Trials Group, Queen's University, Kingston, Canada
¹⁵Wake Forest University, Winston-Salem, NC
¹⁶Division of Hematology/Oncology, Tufts Medical Center, Boston, MA

Tara O Henderson, MD, MPH¹, Susan K Parsons, MD, MRP^2*, Kristen Wroblewski, MS^3*, Lu Chen, PhD^4*, Fangxin Hong, Ph.D.⁵, Sonali M. Smith, MD⁶, Jennifer McNeer, MD, MS¹, Ranjana Advani⁷, Randy D. Gascoyne⁸, Louis Constine, M.D.⁹, Sandra J Horning, MD¹⁰, Nancy L Bartlett, MD¹¹, Bijal D. Shah, MD¹², Joseph M. Connors, MD¹³, John P. Leonard, MD¹⁴, Brad S. Kahl, MD¹⁵, Kara M. Kelly, MD¹⁶, Cindy Schwartz, MD¹⁷, Debra L. Friedman, MD, MS¹⁸, Leo I. Gordon, MD¹⁹ and Andrew M. Evens, DO, MSc²⁰

¹Comer Children's Hospital, University of Chicago, Chicago, IL
²Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Departments of Medicine and Pediatrics, Boston, MA
³Department of Health Sciences, University of Chicago, Chicago, IL
⁴Children's Oncology Group, Acadia, CA
⁵Dana-Farber Cancer Institute, Boston, MA
⁶University of Chicago, Chicago, IL
⁷Stanford Cancer Center, Stanford, CA
⁸British Columbia Cancer Agency, Centre for Lymphoid Cancer, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada
⁹University of Rochester, James P. Wilmot Cancer Center, Rochester, NY
¹⁰Genentech, Inc., South San Francisco, CA
¹¹Washington University School of Medicine, Siteman Cancer Center, Saint Louis, MO
¹²Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹³British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
¹⁴Department of Medicine, Weill Cornell Medical College, New York, NY
¹⁵Department of Medicine-Hematology/Oncology, University of Wisconsin, Madison, WI
¹⁶Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Medical Center, New York, NY
¹⁷MD Anderson Cancer Center, Houston, TX
¹⁸Vanderbilt-Ingram Cancer Center, Nashville, TN
¹⁹Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
²⁰Tufts Medical Center Cancer Center, Boston, MA

Wenbin Xao, MD, PhD^1*, Wayne Chen, MD, PhD^1*, Lynn Sorbara, PhD^1*, Theresa Davies-Hill^1*, Stefania Pittaluga, MD, PhD², Mark Raffeld, MD³ and Elaine S Jaffe, MD²

¹Center for Cancer Research, National Cancer Institute, Bethesda, MD
²Laboratory of Pathology, National Cancer Institute, Bethesda, MD
³Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD

Stefan Nagel, PhD^*, Corinna Meyer^*, Maren Kaufmann^*, Roderick MacLeod^* and Hans G. Drexler, MD, PhD

Human and Animal Cell Lines, Leibniz-Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany

Paul G. Rubinstein, MD¹, Andrea B. Moffitt^2*, Kelly A. Petrowski, MPH^3*, Marina Messinger, MD^4*, Nicholas Davis^2*, Cassandra Love^2*, Sandeep Dave, MD⁵ and Amy Chadburn, MD⁶

¹Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
²Duke University, Durham, NC
³The Ruth M. Rothstein CORE Center, Chicago, IL
⁴John H. Stroger Jr. Hospital of Cook County, Chicago, IL
⁵Duke Cancer Institute, Duke University Medical Center, Durham, NC
⁶Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY

Tarsheen K. Sethi, MD, MS¹, Van T Nguyen, MD^2*, David S Morgan, MD³, John P. Greer, MD³ and Nishitha M Reddy, M.B.B.S.³

¹Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
²Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
³Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN